Galectin-3: biomarker evidence

Galectin-3 appears in 1 entry of the OSMF biomarker atlas, covering Atrial Fibrillation. Across those entries it is elevated in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Atrial Fibrillation

Where Galectin-3 is reported

ConditionDirectionCompared againstAssociated symptomsSource
Atrial Fibrillation↑ elevatedpatients without atrial fibrillation (among those undergoing heart surgery)—Doulamis et al. 2019

Frequently asked questions

In which conditions is Galectin-3 altered?

In the OSMF atlas Galectin-3 is reported in Atrial Fibrillation. It is elevated in 1 across 1 entries.

Is there a standard clinical test for Galectin-3?

The atlas entries for Galectin-3 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Galectin-3 result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Galectin-3 across conditions: biomarker evidence. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/markers/galectin-3.html

Last reviewed: 2026-10-08 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.